» Articles » PMID: 22120910

Calibration of FRAX ® 3.1 to the Dutch Population with Data on the Epidemiology of Hip Fractures

Overview
Journal Osteoporos Int
Date 2011 Nov 29
PMID 22120910
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: The FRAX tool has been calibrated to the entire Dutch population, using nationwide (hip) fracture incidence rates and mortality statistics from the Netherlands. Data used for the Dutch model are described in this paper.

Introduction: Risk communication and decision making about whether or not to treat with anti-osteoporotic drugs with the use of T-scores are often unclear for patients. The recently developed FRAX models use easily obtainable clinical risk factors to estimate an individual's 10-year probability of a major osteoporotic fracture and hip fracture that is useful for risk communication and subsequent decision making in clinical practice. As of July 1, 2010, the tool has been calibrated to the total Dutch population. This paper describes the data used to develop the current Dutch FRAX model and illustrates its features compared to other countries.

Methods: Age- and sex-stratified hip fracture incidence rates (LMR database) and mortality rates (Dutch national mortality statistics) for 2004 and 2005 were extracted from Dutch nationwide databases (patients aged 50+ years). For other major fractures, Dutch incidence rates were imputed, using Swedish ratios for hip to osteoporotic fracture (upper arm, wrist, hip, and clinically symptomatic vertebral) probabilities (age- and gender-stratified). The FRAX tool takes into account age, sex, body mass index (BMI), presence of clinical risk factors, and bone mineral density (BMD).

Results: Fracture incidence rates increased with increasing age: for hip fracture, incidence rates were lowest among Dutch patients aged 50-54 years (per 10,000 inhabitants: 2.3 for men, 2.1 for women) and highest among the oldest subjects (95-99 years; 169 of 10,000 for men, 267 of 10,000 for women). Ten-year probability of hip or major osteoporotic fracture was increased in patients with a clinical risk factor, lower BMI, female gender, a higher age, and a decreased BMD T-score. Parental hip fracture accounted for the greatest increase in 10-year fracture probability.

Conclusion: The Dutch FRAX tool is the first fracture prediction model that has been calibrated to the total Dutch population, using nationwide incidence rates for hip fracture and mortality rates. It is based on the original FRAX methodology, which has been externally validated in several independent cohorts. Despite some limitations, the strengths make the Dutch FRAX tool a good candidate for implementation into clinical practice.

Citing Articles

Cost-Effectiveness Analysis of CT-Based Finite Element Modeling for Osteoporosis Screening in Secondary Fracture Prevention: An Early Health Technology Assessment in the Netherlands.

Li J, Viceconti M, Li X, Bhattacharya P, Naimark D, Osseyran A MDM Policy Pract. 2023; 8(2):23814683231202993.

PMID: 37900721 PMC: 10605708. DOI: 10.1177/23814683231202993.


Romosozumab efficacy and safety in European patients enrolled in the FRAME trial.

Langdahl B, Hofbauer L, Ferrari S, Wang Z, Fahrleitner-Pammer A, Gielen E Osteoporos Int. 2022; 33(12):2527-2536.

PMID: 36173415 PMC: 9652294. DOI: 10.1007/s00198-022-06544-2.


Bone material strength index as measured by in vivo impact microindentation is normal in subjects with high-energy trauma fractures.

Schoeb M, Winter E, Malgo F, Schipper I, van der Wal R, Papapoulos S Osteoporos Int. 2022; 33(7):1511-1519.

PMID: 35307747 PMC: 9187533. DOI: 10.1007/s00198-022-06368-0.


Bone Material Strength Index as Measured by Impact Microindentation is Low in Patients with Primary Hyperparathyroidism.

Schoeb M, Winter E, Sleddering M, Lips M, Schepers A, Snel M J Clin Endocrinol Metab. 2021; 106(7):e2527-e2534.

PMID: 33780545 PMC: 8266436. DOI: 10.1210/clinem/dgab207.


Homogeneity in prediction of survival probabilities for subcategories of hipprosthesis data: the Nordic Arthroplasty Register Association, 2000-2013.

Bartz-Johannessen C, Furnes O, Fenstad A, Lie S, Pedersen A, Overgaard S Clin Epidemiol. 2019; 11:519-524.

PMID: 31402836 PMC: 6637139. DOI: 10.2147/CLEP.S199227.


References
1.
van Helden S, Cals J, Kessels F, Brink P, Dinant G, Geusens P . Risk of new clinical fractures within 2 years following a fracture. Osteoporos Int. 2005; 17(3):348-54. DOI: 10.1007/s00198-005-2026-x. View

2.
de Vries F, Pouwels S, Lammers J, Leufkens H, Bracke M, Cooper C . Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case-control study. J Intern Med. 2007; 261(2):170-7. DOI: 10.1111/j.1365-2796.2006.01754.x. View

3.
McCloskey E, Johansson H, Oden A, Kanis J . From relative risk to absolute fracture risk calculation: the FRAX algorithm. Curr Osteoporos Rep. 2009; 7(3):77-83. DOI: 10.1007/s11914-009-0013-4. View

4.
Siris E, Brenneman S, Barrett-Connor E, Miller P, Sajjan S, Berger M . The effect of age and bone mineral density on the absolute, excess, and relative risk of fracture in postmenopausal women aged 50-99: results from the National Osteoporosis Risk Assessment (NORA). Osteoporos Int. 2006; 17(4):565-74. DOI: 10.1007/s00198-005-0027-4. View

5.
Hans D, Kanis J, Baim S, Bilezikian J, Binkley N, Cauley J . Joint Official Positions of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX(®). Executive Summary of the 2010 Position Development Conference on Interpretation and use of FRAX® in clinical.... J Clin Densitom. 2011; 14(3):171-80. DOI: 10.1016/j.jocd.2011.05.007. View